HomeCALC • NASDAQ
Calcimedica Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.74M | 18.68% |
Net income | -5.62M | -21.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.72M | -18.67% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.60M | 0.08% |
Total assets | 16.21M | 2.32% |
Total liabilities | 7.18M | 94.85% |
Total equity | 9.03M | — |
Shares outstanding | 13.48M | — |
Price to book | 6.30 | — |
Return on assets | -76.96% | — |
Return on capital | -125.42% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.62M | -21.63% |
Cash from operations | -4.67M | -2.10% |
Cash from investing | 8.75M | 397.42% |
Cash from financing | 16.00K | -77.78% |
Net change in cash | 4.10M | 155.05% |
Free cash flow | -2.71M | -4.62% |
Previous close
$5.29
Day range
$4.31 - $5.29
Year range
$0.44 - $7.10
Market cap
24.81M USD
Avg Volume
10.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
Jan 1, 2011
Headquarters
Website
Employees
14
